Starbucks Coffee (SBUX): Cutting PT But Near Term SSS Looks Strong - RBC
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
RBC Capital analyst, David Palmer, reiterated his Outperform rating on shares of Starbucks (NASDAQ: SBUX) but cut his price target to $64 from $68. Despite cutting the price target on slightly lower SSS growth estimates in FY17, he is retaining his 5% SSS estimate for F4Q16 due to results from a proprietary consumer panel which implies 4-6% SSS growth near term.
In short, the analyst sees the company as a good risk/reward at 25x projected FY17 EPS with a PEG ratio of ~1.5x on long-term growth of 17%.
Shares of Starbucks closed at $52.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- UPDATE: SunTrust Robinson Humphrey Downgrades Health Care REIT (HCN) to Hold
- Starbucks Coffee (SBUX): Checks Coincide with 4% Comp Consensus - Wedbush
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS View, Analyst PT Change
Related EntitiesRBC Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!